The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; Janssen-Cilag; Sanofi
Travel, Accommodations, Expenses - Bayer; Janssen-Cilag
Long term results and patterns of recurrence from SCOPE 1: A phase II/III randomised trial of definitive chemoradiotherapy (dCRT) plus or minus cetuximab (dCRT+C) in esophageal cancer.
 
Somnath Mukherjee
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
 
Chris Hurt
No Relationships to Disclose
 
Stephen Falk
Travel, Accommodations, Expenses - Amgen
 
Simon Gollins
No Relationships to Disclose
 
John Staffurth
No Relationships to Disclose
 
Ruby Ray
No Relationships to Disclose
 
John A. Bridgewater
Consulting or Advisory Role - Merck Serono
Speakers' Bureau - Merck Serono
Travel, Accommodations, Expenses - Merck Serono; MSD
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)
 
Jane M. Blazeby
No Relationships to Disclose
 
Rajarshi Roy
Travel, Accommodations, Expenses - Sanofi
 
Tim Maughan
Consulting or Advisory Role - Vertex
Research Funding - AstraZeneca (Inst); Pfizer (Inst)
 
Gareth Griffiths
Consulting or Advisory Role - GlaxoSmithKline; Sirtex Medical
 
Tom David Lewis Crosby
Honoraria - Lilly